Insights from the SEMDA 2018 Marketing & Regulatory Session featuring GCMI’s Mike Fisher

The Marketing & Regulatory Session at SEMDA 2018 explored the goals, responsibilities, and possible pathways of medtech marketers when building awareness and adoption for their products. This session featured panelists Mike Fisher, Director of Product Development for GCMI; Allyson Bower-Willner, Senior Marketing Manager for Molnlycke; and Machelle Shields, Senior Executive Healthcare Policy & Compliance Advisor…

HRS 2018 Insights: Read about future technologies and how T3 Labs can be your partner in emerging EP research.

As the leading annual electrophysiology event, HRS will always bring the latest advancements in pacing, ablation and mapping to the society’s annual meeting. The 2018 edition was no exception and included a few variations on atrial fibrillation (AF) ablations. Catheter Ablation vs/ Antiarrhythmic Drug Therapy The big news from the show was the dissemination of…

Is one young Georgia Tech company about to end complications from epidural misplacement? Read about their experience at T3 Labs.

“It is exceedingly rare for student medtech projects to become companies,” Rains said. “But in a very intentional way, and thanks to a robust local and regional medtech ecosystem, that is exactly what is happening here.” Among the approximately 4 million births in the United States each year, 2.4 million of those mothers elect to…

Industry leading speakers including GCMI, JPMorgan, AdvaMed, Halyard and more announced for SEMDA 2018

Earlier this week, the Southeastern Medical Device Association announced several industry leading plenary and keynote speakers set for next month’s 2018 SEMDA Annual Medtech Conference in Greenville, South Carolina. Representing GCMI, and its Design and Development line of service, our Product Development Director, Mike Fisher will serve on a panel led by Paul Snyder, VP of…